MedTrace Logo

Multi Centre Study on TESS V2 Shoulder System

NCT03431857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2021-10-19

Study results available
· View outcomes & findings →

Summary

This study is a Post Market Clinical Follow-up study to fulfill the post market surveillance requirements. The data collected from this study will serve the purpose of confirming safety and performance of the TESS Shoulder System.

Conditions

  • Osteoarthritis Shoulder
  • Fracture
  • Rheumatoid Arthritis
  • Avascular Necrosis
  • Rotator Cuff Tear
  • Revision

Interventions

DEVICE

TESS V2

Patients requiring the TESS V2 prosthesis.

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Paola Vivoda · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-20
Primary Completion
2015-12-31
Completion
2019-12-31

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03431857 on ClinicalTrials.gov